Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2024 08:15 ET | Source: Napigen, Inc.

NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant

The USPTO issued a patent to NAPIGEN for the use of CRISPR technologies to edit organellar genomes. Separately, USDA awarded NAPIGEN an SBIR phase 1 grant.